Annexin V Binding Buffer

Pricing & Availability
Regulatory Status
RUO
Other Names
Annexin-V-Binding Buffer
Ave. Rating
Submit a Review
Product Citations
publications
Cat # Size Price Save
422201 100 mL ¥6,930
Description

Annexin V Binding Buffer has been formulated for flow cytometric labeling of apoptotic cells with Annexin V reagents.  The buffer is provided as a ready-to-use solution.

Product Details
Technical data sheet

Product Details

Storage & Handling
Store between 2°C and 8°C.
Application

FC - Quality tested

Recommended Usage

Annexin V Binding Buffer is recommended for use with Annexin V reagents. Cells should be resuspended in Annexin V Binding Buffer at a concentration 1x106/ml and then combined with Annexin V reagents at the recommended volumes.

Application Notes

Annexin V Staining
1. Wash cells twice with cold BioLegend cell staining buffer (cat # 420201) and then resuspend cells in Annexin V Binding Buffer (cat # 422201) at a concentration of 1x106 cells/ml.
2. Transfer 100 µl of cell suspension in 5 ml test tube.
3. Add 5 µl of fluorochrome conjugated Annexin V.
4. Add 10 µl of PI solution (cat # 421301) or 7-AAD (cat # 420403/420404).
5. Gently vortex the cells and incubate for 15 min at RT (25 °C) in the dark.
6. Add 400 µl of Annexin V Binding Buffer (cat # 422201) to each tube. Analyze by flow cytometry.


For a better experience detecting apoptosis, we now recommend Apotracker™. Cell staining with Apotracker™ is Calcium independent. Thus, no special buffers are required, and the protocol can be shortened for single-step co-staining with other reagents.

Application References

(PubMed link indicates BioLegend citation)
  1. Vermes I, et al. 1995. J. Immunol. Methods 184:39.
  2. Soon PS, et al. 2013. Endocr Relat Cancer. 20:1. PubMed
  3. Turner JE, et al. 2013. J Exp Med. PubMed
  4. Lindner JM, et al. 2013. Mol Cell Biol. 33:4628. PubMed
  5. Turner JE, et al. 2013 J. Exp Med. 210:2951. PubMed
  6. Beggs KM, et al. 2014. Toxicol Sci. 137:91. PubMed
  7. Miyazawa M, et al. 2014. Mol Biol Cell. 25:2116. PubMed
  8. Burbulla LF, et al. 2014. Cell Death Dis. 5:1180. PubMed
  9. de Vires M, 2014. Am J Physiol Lung Cell Mol Physiol. 307:240. PubMed
  10. Sahin E, 2014. J. Immunol. 193:1717. PubMed
  11. Xiong R, et al. 2014. Toxicol Appl Pharmacol. 280:285. PubMed
  12. Thakran S, 2015. Invest Ophthalmol Vis Sci. 56:177. PubMed
Product Citations
  1. Tsuji M 2014. Mol Biol Cell. 25:2116. PubMed
  2. Guo H, et al. 2016. Sci Rep. 6:37559. PubMed
  3. Kitazawa M, et al. 2017. PLoS One. 10.1371/journal.pone.0169340. PubMed
  4. Liu M, et al. 2021. Mol Med Rep. 23:00. PubMed
  5. Ocklenburg T, et al. 2021. Sci Rep. 7199:11. PubMed
  6. Shrestha C,et al. 2017. PLoS One. 10.1371/journal.pone.0186169. PubMed
  7. Djeungoue–Petga MA, et al. 2019. Cell Death Dis. 1.069444444. PubMed
  8. Forika G, et al. 2021. Pathol Oncol Res. 27:1610048. PubMed
  9. Lindner J, et al. 2013. Mol Cell Biol. 33:4628. PubMed
  10. Turner J, et al. 2013. J Exp Med. 210:2951. PubMed
  11. Itkin T, et al. 2016. Nature. 532: 323-328. PubMed
  12. Hergott C, et al. 2016. Blood. 127: 2460 - 2471. PubMed
  13. Wang J, et al. 2021. ACS Nano. 15:14360. PubMed
  14. Svoronos AA, et al. 2021. iScience. 24:103208. PubMed
  15. Wang Q, et al. 2022. Nat Commun. 13:3022. PubMed
  16. Olelewe C, et al. 2022. iScience. 25:104340. PubMed
  17. Lim JA, et al. 2018. BMC Cancer. 0.860416667. PubMed
  18. Venter C, et al. 2017. Cell Physiol Biochem. 43:1288. PubMed
  19. Terashima S, et al. 2017. J Radiat Res. 10.1093/jrr/rrx025. PubMed
  20. Kim Y, et al. 2020. J Neurochem. 155:177. PubMed
  21. Liu Y, et al. 2022. Cancer Discov. :. PubMed
  22. Wang M, et al. 2022. Immun Inflamm Dis. 10:e626. PubMed
  23. McNeal AS, et al. 2021. Elife. 10:. PubMed
  24. Soprano M, et al. 2016. PLoS One. 11: 0155970. PubMed
  25. Li L, et al. 2016. Cell Death Dis. 7:e2439. PubMed
  26. Moose DL, et al. 2020. Cell Rep. 30:3864. PubMed
  27. Wurzer H, et al. 2021. Front Immunol. 12:619069. PubMed
  28. Figueroa-Valdés AI, et al. 2021. Front Bioeng Biotechnol. 9:619930. PubMed
  29. Yoshioka H, et al. 2021. Front Cell Dev Biol. 9:621045. PubMed
  30. Dregalla RC, et al. 2021. Stem Cell Res Ther. 12:547. PubMed
  31. Sun V, et al. 2021. Front Immunol. 12:716661. PubMed
  32. Herman KD, et al. 2022. Front Immunol. 13:956991. PubMed
  33. Coray M, et al. 2022. Int J Mol Sci. 23:. PubMed
  34. Vries M, et al. 2014. Am J Physiol Lung Cell Mol Physiol. 307:240. PubMed
  35. Naaman H,et al. 2017. PLoS One. 10.1371/journal.pone.0187077. PubMed
  36. Elakad O, et al. 2022. NPJ Precis Oncol. 6:52. PubMed
  37. Deng J, et al. 2021. Cell Death Dis. 12:978. PubMed
  38. Tian AL, et al. 2021. Cell Death Dis. 12:6. PubMed
  39. Hickman O, et al. 2016. Br J Cancer. 10.1038/bjc.2016.91. PubMed
  40. Hagan AS, et al. 2020. Development. 147:00:00. PubMed
  41. Feng S, et al. 2017. Cancer Sci. 108:12:00. PubMed
  42. Zhou L, et al. 2017. Tumour Biol. 39:1010428317694313. PubMed
  43. Kinsella S, et al. 2021. Cell Rep. 37:109789. PubMed
  44. Wilson AS, et al. 2022. Nat Commun. 13:528. PubMed
  45. Zhang S, et al. 2020. Front Immunol. 1.757638889. PubMed
  46. Li P, et al. 2016. Mol Biol Cell. 27: 2542 - 2553. PubMed
  47. Luca E, et al. 2020. Mol Metab. 36:100967. PubMed
  48. Saint Fleur–Lominy S, et al. 2018. Cell Rep. 24:3045. PubMed
  49. Krishnasamy K,et al. 2017. Nat Commun. . 10.1038/s41467-017-00953-2. PubMed
  50. Yang L, et al. 2021. Cell Death Differ. 28:2616. PubMed
  51. Wu J, et al. 2020. Immunity. 53:115. PubMed
  52. Burbulla L, et al. 2014. Cell Death Dis. 5:1180. PubMed
  53. Peiris T, et al. 2016. Development. 143: 1697 - 1709.. PubMed
  54. Herold N, et al. 2017. Nat Med. 23:256-263. PubMed
  55. Domenis R, et al. 2017. PLoS One. 10.1371/journal.pone.0169932. PubMed
  56. Xie S, et al. 2021. Sci Rep. 0.660416667. PubMed
  57. Hönes J, et al. 2017. Sci Rep. . 10.1038/s41598-017-15866-9. PubMed
  58. Wang P, et al. 2019. Nat Commun. 0.940972222. PubMed
  59. Celus W, et al. 2021. Cancer Immunol Res. Online ahead of print. PubMed
  60. Cheng CC, et al. 2020. Elife. 9:00. PubMed
  61. Leiendecker L, et al. 2020. EMBO Mol Med. 12:e12525. PubMed
  62. Jung E, et al. 2017. J Neurosci. 37:6837. PubMed
  63. Matsuda K, et al. 2021. Cell Rep Methods. 1:100122. PubMed
  64. Carosi JM, et al. 2021. Autophagy. 17:2217. PubMed
  65. Li Y, et al. 2021. Sci Transl Med. 13:. PubMed
  66. Thakran S, et al. 2015. Invest Ophthalmol Vis Sci . 56:177. PubMed
  67. Suarez S, et al. 2015. J Biol Chem. 290: 28311 - 28320. PubMed
  68. Deventhiran J, et al. 2016. J Virol. 90: 222 - 231. PubMed
  69. Verma N, et al. 2020. Sci Adv. 6:00. PubMed
  70. Litzenburger UM, et al. 2017. Genome Biol. 18:15. PubMed
  71. Pedicona F, et al. 2022. Sci Signal. 15:eabl7989. PubMed
  72. Li C, et al. 2021. Cell Metabolism. 33(8):1610-1623.e5. PubMed
  73. L Chang, Y Li, D Kaplan 2016. Sci Rep. 6:36862. PubMed
  74. Becker A, et al. 2016. Sci Rep. 6: 33847. PubMed
  75. Hopkins T, et al. 2015. Nucleic Acids Res. 10.1093/nar/gkv1515. PubMed
  76. Bersini S, et al. 2020. Life Sci Alliance. 3:e201900623. PubMed
  77. Lasrado N, et al. 2022. iScience. 25:103865. PubMed
  78. Yabas M, et al. 2016. PLoS One. 11: 0146774. PubMed
  79. Li B, et al. 2019. Oncol Rep. 41:608. PubMed
  80. Wang M, et al. 2018. Diabetologia. 62:335. PubMed
  81. Textor A, et al. 2021. Cancers (Basel). 13:. PubMed
  82. Molinar-Inglis O, et al. 2021. Proc Natl Acad Sci U S A. 118:. PubMed
  83. Erdogan M, et al. 2022. Chem Biodivers. 19:e202200659. PubMed
  84. Harro CM, et al. 2020. J Clin Invest. . PubMed
  85. Cabet E, et al. 2015. PLoS One. 10: 0137009. PubMed
  86. Hasselluhn MC, et al. 2019. Cell Death Dis. 0.726388889. PubMed
  87. Zhang S, et al. 2018. Sci Rep. 8:17066. PubMed
  88. Lee HW, et al. 2018. Am J Physiol Renal Physiol. 314:F280. PubMed
  89. Pascual-Pasto G, et al. 2022. J Immunother Cancer. 10:. PubMed
  90. Soon P, et al. 2013. Endocr Relat Cancer. 20:1. PubMed
  91. Dong G, et al. 2020. Haematologica. . PubMed
  92. Abu El Maaty MA, et al. 2021. Sci Adv. 7: . PubMed
  93. Bahl S, et al. 2021. Cell Death Dis. 12:469. PubMed
  94. Labi V, et al. 2019. Genes Dev. 33:1673. PubMed
  95. Sun T, et al. 2019. Cancer Med. 2.457638889. PubMed
  96. Kiss M, et al. 2020. Cancer Immunol Res. 9:309. PubMed
  97. Su PL, et al. 2021. Lung Cancer. 158:137. PubMed
  98. Beggs K, et al. 2014. Toxicol Sci. 137:91. PubMed
  99. Guentsch A, et al. 2017. Mol Cell Biol. 37: e00236-16. PubMed
  100. Festag J, et al. 2020. Mol Ther Nucleic Acids. 1.330555556. PubMed
  101. Marton N, et al. 2017. Cellular and Molecular Life Sciences. 10.1007/s00018-017-2535-8. PubMed
  102. Kranz P, et al. 2017. Cell Death Dis. 8:e2986. PubMed
  103. Wu J, et al. 2021. Adv Sci (Weinh). 8:e2101029. PubMed
  104. Kojima N, et al. 2015. Anticancer Res. 35: 4493-4499. PubMed
  105. Xiong R, et al. 2014. Toxicol Appl Pharmacol. 280:285. PubMed
  106. Pedro L, et al. 2019. Small. 15:e1900224. PubMed
  107. Rosenberger L, et al. 2019. Sci Rep. 0.835416667. PubMed
  108. Bensberg M, et al. 2021. Proc Natl Acad Sci U S A. 118:. PubMed
  109. Sahin E, et al. 2014. J Immunol. 193:1717. PubMed
  110. Kim J, et al. 2019. PLoS One. 14:e0210248. PubMed
  111. Quan M, et al. 2019. Oncol Rep. 41:3051. PubMed
  112. Di Franco S, et al. 2021. STAR Protoc. 2:100880. PubMed
  113. Jatho A, et al. 2022. Cells. 11:. PubMed
  114. Langsch S, et al. 2016. Cancer Res . 76: 4160 - 4169. PubMed
  115. Xiong R, et al. 2015. Mol Pharmacol. 88: 1045 - 1054. PubMed
  116. Vancsik T, et al. 2019. Cancer Med. 3.313888889. PubMed
  117. Vulin M, et al. 2022. Oncogene. :. PubMed
  118. Guo P, et al. 2022. Nat Cell Biol. 24:99. PubMed

Antigen Details

Gene ID
NA

Related FAQs

How is your Annexin made and what sequence does it cover?

It is made in E. coli, covering human aa Met1-Asp320.

How does pH and staining temperature affect Annexin V-Phosphatidylserine binding?

Annexin-Phosphatidylserine binding is lost below pH 5.2 and with prolonged incubation over a temperature of 42°C.

Why do I need to use Annexin V Binding Buffer?

Annexin V binding requires the presence of calcium in the solution.  So, we provide Annexin V Binding Buffer (cat # 422201), which is optimized for the best performance of Annexin V staining.

Can I use RPMI during Annexin V staining?

It is best to follow protocol as described on the product data sheet. Moreover, RPMI 1640 has a relatively high concentration of phosphate and low calcium ion concentration, which negatively impacts Annexin binding to its target phosphatidylserine (PS). Measurement of cell death by using Annexin V may also be significantly affected by time of incubation on ice, calcium concentration, and type of medium.

Can I freeze Annexin V conjugates?

It should not be frozen as it will lead to loss of biological activity due to dimerization.

Is Annexin V suitable for conjugation with the Maxpar® kit for CyTOF®?

Maxpar® Labeling kits require the protein to be partially reduced, so the metal chelate can be introduced through an SH group in the hinge region of the reduced antibody. Human Annexin V contains only one Cysteine which was reported to be chemically inactive. Thus, the Maxpar® labeling protocol would not work with Annexin V, unless a free –SH group can be introduced to Annexin V.  For more information regarding SH-mediated conjugation of Annexin V please consult published papers such as this one.

Go To Top Version: 5    Revision Date: 03/15/2021

For research use only. Not for diagnostic use. Not for resale. BioLegend will not be held responsible for patent infringement or other violations that may occur with the use of our products.

 

*These products may be covered by one or more Limited Use Label Licenses (see the BioLegend Catalog or our website, www.biolegend.com/ordering#license). BioLegend products may not be transferred to third parties, resold, modified for resale, or used to manufacture commercial products, reverse engineer functionally similar materials, or to provide a service to third parties without written approval of BioLegend. By use of these products you accept the terms and conditions of all applicable Limited Use Label Licenses. Unless otherwise indicated, these products are for research use only and are not intended for human or animal diagnostic, therapeutic or commercial use.

 

BioLegend Inc., 8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.

ProductsHere

Login / Register
Remember me
Forgot your password? Reset password?
Create an Account